Kythera Biopharmaceuticals

Kythera Biopharmaceuticals is a publicly traded company as of October 2012.
Below is PrivCo's archived report for Kythera Biopharmaceuticals

What's included with your PrivCo Report Purchase:

Next Actions on Kythera Biopharmaceuticals:

Business Summary

Kythera Biopharmaceuticals is a privately-held, venture capital backed biotechnology company. Kythera Biopharmaceuticals is headquartered in Calabasas, California.

Overview & Corporate Organization

Basic Information

Company Tags:	VC Backed
Fiscal Year End:	12/31
1YR Revenue Growth Rate:	View %
City:	Calabasas
State/Province:	California
Country:	United States
Phone:	View
Website:	www.kytherabiopharma.com

Industry Information

Industry Codes

PICS™:	15001™
NAICS:	View
SIC:	View

PrivCo Industries (Sector > Industry > Sub-Industry)

Technology > Biotechnology

The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.

Ownership

PrivCo's Ownership table displays who owns Kythera Biopharmaceuticals, including owner name, each type of owner (whether family, individual, private equity firm, etc.)

Owner Name	Type of Owner	% Ownership Stake
View	View	View
View	View	View
View	View	View
View	View	View

Charts, Financials, and Statistics (Table Format)

Below are Kythera Biopharmaceuticals financials and other business metrics displayed in table format.
Copy & Paste Financials Into Spreadsheet or

Export All Kythera Biopharmaceuticals Financials To Excel

All data before 2006 is completely free to view! To access data from 2006 onward:

Worldwide
United States
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Washington, D.C.
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Puerto Rico
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Canada
Alberta
British Columbia
Manitoba
New Brunswick
Newfoundland and Labrador
Northwest Territories
Nova Scotia
Nunavut
Ontario
Prince Edward Island
Quebec
Saskatchewan
Yukon
Europe (all countries)
UK
Germany
France
Italy
Europe (excluding UK)
Asia-Pacific (all countries)
Australia
China
Hong Kong
India
South Korea
Taiwan
Japan
Asia-Pacific (excluding India)
Latin America (all countries)
Middle East & Africa (all countries)

Get Full Access To This Report	or	Upgrade to PrivCo Premium
$99 Single Company Access		Instant Full Site-Wide Access *Currently 50% Off Until May. 31!*

Income Statement	2011	2010	2009
Revenues	View	View
Gross Profit	View	View
Total Operating Expenses	View	View	View
Operating Income (Loss)	View	View	View
Net Interest Income	View	View	View
Net Income (Loss)	View	View	View
Expenses	View	View
Balance Sheet	2011	2010	2009
Current Assets	View	View
Cash and Cash Equivalents	View	View
Other Non-Current Assets	View	View
Total Assets	View	View
Current Liabilities	View	View
Total Liabilities	View	View
Stockholders Equity	View	View
Total Liabilities and Stockholders' Equity	View	View
Cash Flow Statement	2011	2010	2009
Cash Flow From Operating Activities	View	View	View
Cash Flow From Investing Activities	View	View	View
Cash Flow From Financing Activities	View	View	View
Total Cash Flow (Net Change in Cash)	View	View	View
Cash & Cash Equivalents End of Year	View	View	View
Cash & Cash Equivalents Beginning of Year	View	View	View
Net Loss	View	View	View

Financial Notes:
*	Kythera Biopharmaceuticals fiscal year end: 12/31

	Date	Investor	Round	Investor Type
	Sep. 2005	Versant Ventures	Funding	Venture Capital
Details		Total Round Funding $1,000,000
	Jul. 2006	View	B	Venture Capital
	Jul. 2006	View	B	Venture Capital
	Jul. 2006	View	B	Venture Capital
	Jul. 2006	View	B	Venture Capital
	Jul. 2006	View	B
	Jul. 2006	View	B	Other Investment Firm
Details		Total Round B View
	May. 2008	View	C	Venture Capital
	May. 2008	View	C	Venture Capital
	May. 2008	View	C	Venture Capital
	May. 2008	View	C	Venture Capital
	May. 2008	View	C
	May. 2008	View	C
	May. 2008	View	C
	May. 2008	View	C	Venture Capital
	May. 2008	View	C	Venture Capital
Details		Total Round C View
	Sep. 2009	View	Other	Venture Capital
	Sep. 2009	View	Other	Venture Capital
	Sep. 2009	View	Other	Venture Capital
	Sep. 2009	View	Other	Venture Capital
Details		Total Round Other View
	Sep. 2011	View	D	Venture Capital
	Sep. 2011	View	D	Venture Capital
	Sep. 2011	View	D	Venture Capital
	Sep. 2011	View	D	Venture Capital
	Sep. 2011	View	D	Private Equity
	Sep. 2011	View	D	Venture Capital
	Sep. 2011	View	D	Venture Capital
	Sep. 2011	View	D	Venture Capital
Details		Total Round D⁵ View
		Total of Funding Shown Above View

1	Camille...Read More →
2	Robert...Read More →
3	David...Read More →
4	Hironori...Read More →
5	According to an SEC filing,...Read More →
	Full-length notes are available with Single Report Access or PrivCo Premium Subscription.

	Date	Deal Type	Action	Resulting Status	Valuation	Amount Raised	Public Ticker
Details	Oct. 2012	View	View	View¹	View	View	View

1	Offered 4.4...Read More →
	Full-length notes are available with Single Report Access or PrivCo Premium Subscription.

Choose Region(s):
Or Enter Location (US, CAN, UK): within miles
Annual Revenues search is available on PrivCo Premium. Upgrade to PrivCo Premium Subscription Annual Revenues:
Industry:
Go to Advanced Search

Kythera Biopharmaceuticals

Business Summary

Overview & Corporate Organization

Basic Information

Industry Information

Industry Codes

PrivCo Industries (Sector > Industry > Sub-Industry)

Ownership

Charts, Financials, and Statistics (Table Format)

Charts, Financials, and Statistics (Graphs)

Kythera Biopharmaceuticals Revenues ($ MM): (Displayed as graph)

Kythera Biopharmaceuticals Gross Profit ($ MM): (Displayed as graph)

Kythera Biopharmaceuticals Total Operating Expenses ($ MM): (Displayed as graph)

Kythera Biopharmaceuticals Operating Income (Loss) ($ MM): (Displayed as graph)

Kythera Biopharmaceuticals Net Interest Income ($): (Displayed as graph)

Kythera Biopharmaceuticals Net Income (Loss) ($ MM): (Displayed as graph)

Kythera Biopharmaceuticals Expenses ($ MM): (Displayed as graph)

Kythera Biopharmaceuticals Current Assets ($ MM): (Displayed as graph)

Kythera Biopharmaceuticals Cash and Cash Equivalents ($ MM): (Displayed as graph)

Kythera Biopharmaceuticals Other Non-Current Assets ($): (Displayed as graph)

Kythera Biopharmaceuticals Total Assets ($ MM): (Displayed as graph)

Kythera Biopharmaceuticals Current Liabilities ($ MM): (Displayed as graph)

Kythera Biopharmaceuticals Total Liabilities ($ MM): (Displayed as graph)

Kythera Biopharmaceuticals Stockholders Equity ($ MM): (Displayed as graph)

Kythera Biopharmaceuticals Total Liabilities and Stockholders' Equity ($ MM): (Displayed as graph)

Kythera Biopharmaceuticals Cash Flow From Operating Activities ($ MM): (Displayed as graph)

Kythera Biopharmaceuticals Cash Flow From Investing Activities ($ MM): (Displayed as graph)

Kythera Biopharmaceuticals Cash Flow From Financing Activities ($ MM): (Displayed as graph)

Kythera Biopharmaceuticals Total Cash Flow (Net Change in Cash) ($ MM): (Displayed as graph)

Kythera Biopharmaceuticals Cash & Cash Equivalents End of Year ($ MM): (Displayed as graph)

Kythera Biopharmaceuticals Cash & Cash Equivalents Beginning of Year ($ MM): (Displayed as graph)

Kythera Biopharmaceuticals Net Loss ($ MM): (Displayed as graph)

VC/Funding Activity

Public / Private History (PPH™)

Supplemental Resources

PrivCo Private Deals Newsletter.It's FREE!

Who We Serve

Problems We Solve

PrivCo

Kythera Biopharmaceuticals Revenues ($ MM):
(Displayed as graph)

Kythera Biopharmaceuticals Gross Profit ($ MM):
(Displayed as graph)

Kythera Biopharmaceuticals Total Operating Expenses ($ MM):
(Displayed as graph)

Kythera Biopharmaceuticals Operating Income (Loss) ($ MM):
(Displayed as graph)

Kythera Biopharmaceuticals Net Interest Income ($):
(Displayed as graph)

Kythera Biopharmaceuticals Net Income (Loss) ($ MM):
(Displayed as graph)

Kythera Biopharmaceuticals Expenses ($ MM):
(Displayed as graph)

Kythera Biopharmaceuticals Current Assets ($ MM):
(Displayed as graph)

Kythera Biopharmaceuticals Cash and Cash Equivalents ($ MM):
(Displayed as graph)

Kythera Biopharmaceuticals Other Non-Current Assets ($):
(Displayed as graph)

Kythera Biopharmaceuticals Total Assets ($ MM):
(Displayed as graph)

Kythera Biopharmaceuticals Current Liabilities ($ MM):
(Displayed as graph)

Kythera Biopharmaceuticals Total Liabilities ($ MM):
(Displayed as graph)

Kythera Biopharmaceuticals Stockholders Equity ($ MM):
(Displayed as graph)

Kythera Biopharmaceuticals Total Liabilities and Stockholders' Equity ($ MM):
(Displayed as graph)

Kythera Biopharmaceuticals Cash Flow From Operating Activities ($ MM):
(Displayed as graph)

Kythera Biopharmaceuticals Cash Flow From Investing Activities ($ MM):
(Displayed as graph)

Kythera Biopharmaceuticals Cash Flow From Financing Activities ($ MM):
(Displayed as graph)

Kythera Biopharmaceuticals Total Cash Flow (Net Change in Cash) ($ MM):
(Displayed as graph)

Kythera Biopharmaceuticals Cash & Cash Equivalents End of Year ($ MM):
(Displayed as graph)

Kythera Biopharmaceuticals Cash & Cash Equivalents Beginning of Year ($ MM):
(Displayed as graph)

Kythera Biopharmaceuticals Net Loss ($ MM):
(Displayed as graph)

PrivCo Private Deals Newsletter.
It's FREE!